Fluxion Biosciences

Fluxion Biosciences Initiates Early Access Program
for the IonFux Automated Electrophysiology System

System provides automated solution for performing ion channel assays in drug discovery and development

San Francisco, CA, April 20, 2006 - Fluxion Biosciences today announced the initiation of early access sales of its IonFlux platform, which provides automated cellular electrophysiology assays for drug discovery and development. The system automates the slow and skill-sensitive “patch clamp” assay that is the benchmark assay for ion channel research.

The IonFlux system utilizes a unique microfluidic design to provide automated cell manipulation, trapping, sealing, whole-cell formation, and precise e-field application. The IonFlux system delivers outstanding patch clamp performance in a complete, easy-to-use system. In addition, it offers significant advantages in throughput, compound application, and imaging capabilities. The early access system includes the IonFlux instrument as well as IonPlate consumables. The system integrates easily with existing manual patch clamp workflows. Additionally, the IonFlux system is suitable for performing single-cell electroporation assays.

According to Andrew Blatz, Ph.D., Director of Marketing Applications, “The IonFlux early access program has been initiated after strong initial feedback from trial users. We have maintained close contact with users during the system’s development to ensure it meets their needs. Based on the IonFlux System’s dramatic performance benefits, these users are eager to include IonFlux in their hERG toxicity and ion channel drug discovery programs.” Early access IonFlux systems are available immediately.

Fluxion Biosciences develops cellular analysis tools for use in critical applications in life research and drug discovery. Fluxion has developed a proprietary microfluidic platform, CellFlux, which enables precise cellular manipulation, rapid low-volume compound addition, environmental control, and software-based data acquisition. Products include the BioFlux System for biofilm and cellular adhesion analysis, IonFlux System for cellular electrophysiology, and the CytoFlux System for stop-flow cellular imaging. These products meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, simple to use "operating system" for cellular biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.



		Fluxion Biosciences Initiates Early Access Program for the IonFux Automated Electrophysiology System System provides automated solution for performing ion channel assays in drug discovery and development San Francisco, CA, April 20, 2006 - Fluxion Biosciences today announced the initiation of early access sales of its IonFlux platform, which provides automated cellular electrophysiology assays for drug discovery and development. The system automates the slow and skill-sensitive “patch clamp” assay that is the benchmark assay for ion channel research. The IonFlux system utilizes a unique microfluidic design to provide automated cell manipulation, trapping, sealing, whole-cell formation, and precise e-field application. The IonFlux system delivers outstanding patch clamp performance in a complete, easy-to-use system. In addition, it offers significant advantages in throughput, compound application, and imaging capabilities. The early access system includes the IonFlux instrument as well as IonPlate consumables. The system integrates easily with existing manual patch clamp workflows. Additionally, the IonFlux system is suitable for performing single-cell electroporation assays. According to Andrew Blatz, Ph.D., Director of Marketing Applications, “The IonFlux early access program has been initiated after strong initial feedback from trial users. We have maintained close contact with users during the system’s development to ensure it meets their needs. Based on the IonFlux System’s dramatic performance benefits, these users are eager to include IonFlux in their hERG toxicity and ion channel drug discovery programs.” Early access IonFlux systems are available immediately. About Fluxion Biosciences Fluxion Biosciences develops cellular analysis tools for use in critical applications in life research and drug discovery. Fluxion has developed a proprietary microfluidic platform, CellFlux, which enables precise cellular manipulation, rapid low-volume compound addition, environmental control, and software-based data acquisition. Products include the BioFlux System for biofilm and cellular adhesion analysis, IonFlux System for cellular electrophysiology, and the CytoFlux System for stop-flow cellular imaging. These products meet the rigorous demands of life science and drug discovery scientists by providing an intuitive, simple to use "operating system" for cellular biology. For more information about Fluxion Biosciences, visit www.fluxionbio.com.


Home About Products Technology News Contact © 2007 Fluxion Biosciences, Inc. All rights reserved. "BioFlux", "CytoFlux" and "IonFlux" are trademarks of Fluxion Biosciences, Inc.